Catheters Market Share

Catheters Market Overview

The Catheters Market Size was valued at USD 25.84 Billion in 2023. The global catheters industry is projected to grow from USD 28.57 Billion in 2024 to USD 59.13 Billion by 2032, exhibiting a CAGR of 8.42% during the forecast period (2024 - 2032).

A catheter is a thin tube medical device made from superior graded material sourced in the healthcare sector to distribute gases, medications, or fluids to patients or remove bodily fluids such as urine. These are implanted into the body to cure numerous diseases and perform surgeries.

March 2024 – CoapTech, Inc., a medical device firm specializing in minimally-invasive surgery, has announced the market release and groundbreaking initial usage of its second generation magnetic balloon catheter at the patient's bedside. The magnetic balloon catheter is an essential part of the PUMA-G System™, which allows for the precise installation of gastrostomy tubes (i.e. permanent feeding tubes) using ultrasonography. These tubes are vital for providing patients with the necessary nutrition to aid in their rehabilitation. The PUMA-G System is produced in Baltimore in partnership with The LaunchPort™.

Coaptech exemplifies the vast possibilities that emerge from the medtech environment in Maryland. The technology originated from the research institutions in our region, and there was significant help during the stage of adapting it for practical use from the early-stage grants provided by the City and State. Upon introducing their innovative products, they strategically set up their production operations in Baltimore, thus completing a cycle of support for the region that originally fostered their growth. The Coaptech team has numerous further milestones ahead.

In January 2024, Royal Philips, a prominent company in health technology, revealed that its newest TEE transducer, which aims to provide better comfort and serve a larger number of patients, had obtained FDA 510(k) clearance. Cardiovascular ultrasound has been essential in advancing the early detection of structural heart disease, thanks to the development of a groundbreaking technique known as transesophageal echocardiography (TEE) ultrasound transducer, pioneered by Philips. 

Transesophageal echocardiography (TEE) assists cardiologists by offering intricate visualizations of the heart and its intrinsic anatomical features. The quality of a three-dimensional transesophageal echocardiography (3D TEE) image plays a crucial role in the management of structural heart disease, potentially leading to life-saving interventions. 3D graphics surpass 2D equivalents in terms of clarity and perspective. Transesophageal echocardiography (TEE) is a highly useful instrument for performing minimally invasive cardiac surgeries and procedures. It has revolutionized the treatment of heart valve problems and congenital heart defects.

In January 2024, Cook Medical introduced its Slip-Cath Beacon catheter under the brand name Tip Hydrophilic Selective, which can be used for both Canadian and American patients. This particular hydrophilic catheter is specifically designed to suit a wide range of vascular and nonvascular procedures. It is used in angiographic proceedings along with vascular access sheaths, wire guides and other treatment instruments.

In October 2023, B. Braun rolled out the Introcan Safety 2 IV Catheter with multiple-access blood control for protecting clinicians every time the hub is accessed.

In October 2023, Linear Health Sciences announced FDA approval of Orchid SRV safety release valves. This catheter had been allowed for use on all IV accesses, such as intravascular catheters rupture; however it was offered to prevent this from happening in hospitals.

May 2023, BD came up with a pre-filled flush syringe that was convenient for customers. Flushing and disinfecting IV catheters during clinical operations has been made much easier by an innovative BD PosiFlush SafeScrub syringe that supports patient care delivery. Cleansing of these tubes should be regarded as important since it stops CRBSIs from recurring. Infection prevention guidelines have increasingly drawn more attention towards infection prevention measures which have necessitated correct flushing and disinfecting of catheters.

The Asia Pacific Society of Infection Control unveiled the APSIC guide on preventing urinary tract infections associated with urinary catheters in July 2022. The purpose of this project was to offer brief practical recommendations to healthcare facilities in Asia Pacific on infection prevention & management. Its main objective was to help nurses manage and care better among those patients who are using a urinary catheter.

In February 2022, Teleflex Incorporated received FDA approval from US regulatory authorities for their specialty crossing chronic total occlusion (CTO) catheters used in Percutaneous Coronary Intervention (PCI) procedures. These specialty catheters come with such characteristics as smoother surfaces, less friction and materials that reduce irritation. This can be individualized to improve the satisfaction level of patients and for situations where prolonged catheterization is required.

COVID-19 Analysis

The onset of the COVID epidemic in March has led to the revision of both the patient and the staff's safety can be ensured by the institution of a set of smart strategies. The COVID pandemic has enforced an update to the typical medical procedures and acclimatize them to the latest situation categorized by an elevated risk of contamination of the health workers. The patients with COVID-19 or suspected cases of the disease requiring intubation should be intubated before advent at the catheterization laboratory. Besides, the threshold to consider intubation in a patient with marginal respiratory status may need to be reduced to prevent emergent intubation in the catheterization laboratory. The huge majority of catheterization laboratories have intended either standard or optimistic ventilation systems and are not intended for infection isolation.

Catheters Market Trends

• Drivers

Increase In Preference For Minimally Invasive Procedures

The rise in the number of patients opting for minimally invasive procedures is foreseen to create an optimistic scope for developing the future catheters market share.

Increasing Number Of Patients Suffering From Urological And Cardiac Problems

Several catheter types, such as urinary catheters, specialty catheters, intravenous catheters, cardiovascular catheters, and neurological catheters, have been made accessible to treat diseases. This is estimated to spur the catheters market size in the upcoming years.

Increasing Geriatric Population

The swell in the geriatric population and diabetic patients who are more prone to contracting cardiac and urological diseases is predicted to motivate the catheters market stake.

• Opportunities

New Advancements In Catheterization Devices

The innovations noted in the catheter design and efficiency are estimated to spur the catheters market's progress.

• Challenges

Risk Of Infection

The emergence of cases in which infection has been contracted through catheter use is estimated to restrict the catheters market's growth.

Catheters Market Segment Insights

Catheters Type Insights

The cardiovascular catheter segment is predicted to control the catheters market's largest share. In contrast, the urinary catheters segment is anticipated to grow at a CAGR of 6.52% in the forecast period.

Catheters End Users Insights

The hospitals & clinics segment accounts for the largest market share in the catheters market by end-users.

Catheters Regional Insights

R & D Capabilities To Boost Americas Region

The Americas catheters market dominates the global catheters market owing to growing elderly residents, massive population base with cardiac diseases, strong government support for research & development, and elevated health care spending.

European Regional Market To Observe Technological Advancement

The regional market of Europe is the next foremost region in the global catheters market, shadowed by the Asia Pacific. The sophisticated technologies in these nations have performed a predominant role in emerging markets in the European region.

APAC Region To Be Advanced By National Markets

The Asia Pacific is the most rapid mounting catheters market, driven by national markets India, China, and Japan due to abundant patient population and a rapidly mounting economy. The healthcare spending in the Asia Pacific has amplified throughout the last few years, adding to catheters market growth.

MEA Region To Add Significantly To Market Share

The Middle East and African regional market add the least to the development of the global catheters market. Saudi Arabia, the UAE, and Kuwait national markets lead the Middle East & African catheters market. The African regional market holds the catheter market's minimum share due to factors such as inadequate medical facilities and poor economic conditions.

Competitive Landscape

The essential companies in the Catheters Market are

• Boston Scientific Corporation,


• Abbott, Medtronic Plc,


• Braun Melsungen Ag,


• Becton, Dickinson, And Company,


• Terumo Corporation,


• Koninklijke Philips N.V,


• Lumend Corporation


• Covidien Ag (Ireland),


• Acist Medical Systems


• Cook Medical Inc.

Recent Developments

Jan 2021 Reflow Medical declared it has launched its Reflow Spex Low Profile strengthened support catheters. The Spex LP catheters are intended to provide the lowest profile tip to access and cross the constricted and most complex lesions with a support system. They are available in 0.014 in. and 0.018 in. sizes and can be blended with the Reflow Spex 35.

Jan 2021 Control Medical Technology declared the FDA cleared Control 11F Mechanical Thrombectomy system was used to remove large blood clots in patients with deep vein thrombosis (DVT). Coronary thrombectomy is executed in acute myocardial infarction (AMI), neurovascular thrombectomy in acute ischemic stroke, and peripheral thrombectomy is performed with chronic total occlusion (CTO), peripheral arterial disease (PAD), and deep vein thrombosis (DVT). Blood-clot and embolic removal, or embolectomy and thrombectomy, is executed through the body. 

Dec 2020 The FDA has ordered Cook Medical's recall of two catheters used in vascular procedures as Class I, the most severe type. There have been at least 57 complaints about the catheters named Flexor Check-Flo Introducers and Flexor Tuohy-Borst Side-Arm Introducers and 14 reports of grave injuries. There have been no informed deaths. The catheters have a covered shaft, a valve, a dilator, and markers that show up on an x-ray and are used to help insert other medical devices consumed for therapy or diagnosis into the vessels, except for those of the heart and brain.

Oct 2020 Johnson & Johnson recently proclaimed that its Biosense Webster business had acquired FDA endorsement for its Thermocool SmartTouch SF ablation catheter. The Thermocool SmartTouch accepted approval for the management of persistent atrial fibrillation.

Aug 2020 Abbott declared it had registered the first contributors in its TactiFlex PAF IDE study to assess the TactiFlex sensor-enabled ablation catheter's performance. The catheter is intended to treat individuals experiencing paroxysmal atrial fibrillation (PAF) with indications that medicine cannot manage.TactiFlex joins Abbott's contact force-sensing technology within the TactiCath SE catheter with a catheter tip design originating in its Flexibility irrigated ablation catheter.

Catheters Market Segmentation

Catheters Type Outlook

• Cardiovascular Catheters


• Specialty Catheters


• Intravenous Catheters


• Urinary Catheters


• Neurological Catheters

Catheters End Users Outlook

• Hospitals & Clinics


• Ambulatory Surgical Centers